RUA Life Sciences released a well-received announcement on an important milestone in the commercialisation of its large bore vascular graft and its related product, the vascular patches. The release also included a trading update on group businesses. As a result of this positive development on RUA’s vascular graft product, we have updated our valuation of the product itself and RUA’s cash position at the end of September 2021.
